510(k) · Cleared
ClearedBoomerang Closurewire Vascular Closure System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Cardiva Medical, Inc. · DXC Clamp, Vascular
Cleared on Dec 6, 2006 as substantially equivalent to K041486 (Cardiva Medical, Inc., 2004) and 2 other predicates after a 519-day review. Its family tree reaches back 1 generation to 1992. 4 later devices descend from it.
- Decided
- Dec 6, 2006
- Review
- 519 days
- Class
- Class II
- Product code
- DXC
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 1 generation to K915280 (1992). 3 ancestors in all. 4 later devices descend from it, 1 citing it directly.
- Root · 1 generation backK915280 FemostopRadi Medical Systems AB · 1992
- This deviceK051817 Boomerang Closurewire Vascular Closure SystemCardiva Medical, Inc. · 2006
- Descendant · cites it directly · 3 of its ownK070485 Boomerang Wire /Boomerang Plus Wire System, Model# B Plus Wire 58LCardiva Medical, Inc. · 2007
- Descendant · 2 generations on · 2 of its ownK072297 Boomerang Catalyst/Boomerang Catalyst II SystemCardiva Medical, Inc. · 2007
- Descendant · 3 generations on · 1 of its ownK082930 Cardiva Catalyst Iii System with Protamine SulfateCardiva Medical, Inc. · 2009
- Descendant · 2 generations on · 0 of its ownK130124 Catalyst II and IiiCardiva Medical, Inc. · 2013
Most influential descendants
Showing 4 of 4 · See all- K070485Boomerang Wire /Boomerang Plus Wire System, Model# B Plus Wire 58LCardiva Medical, Inc. · 2007 · cites it directly3descendants
- K072297Boomerang Catalyst/Boomerang Catalyst II SystemCardiva Medical, Inc. · 2007 · 2 generations on2descendants
- K082930Cardiva Catalyst Iii System with Protamine SulfateCardiva Medical, Inc. · 2009 · 3 generations on1descendant
- K130124Catalyst II and IiiCardiva Medical, Inc. · 2013 · 2 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K915280 | Femostop | Radi Medical Systems AB | 1992 | — |
| 0 (this device) | K051817 | Boomerang Closurewire Vascular Closure System | Cardiva Medical, Inc. | 2006 | — |
| +1 | K070485 | Boomerang Wire /Boomerang Plus Wire System, Model# B Plus Wire 58L | Cardiva Medical, Inc. | 2007 | — |
| +2 | K072297 | Boomerang Catalyst/Boomerang Catalyst II System | Cardiva Medical, Inc. | 2007 | — |
| +3 | K082930 | Cardiva Catalyst Iii System with Protamine Sulfate | Cardiva Medical, Inc. | 2009 | — |
| +2 | K130124 | Catalyst II and Iii | Cardiva Medical, Inc. | 2013 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
| 2004 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 2 | 0 |
| 2009 | 1 | 0 |
| 2013 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DXC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DXC device
- #1 K262086 PreludeSYNC™ Radial Compression Devicescore 13.5 · 7 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K041486 | Vasostasis Vascular Closure SystemSummary page 1…Blood Access Device and Accessories (21 CRF §870.5540) Classification: Class I1 PREDICATE DEVICES Cardiva Medical VasoStasis Vascular Closure System (K041486) Radi Medical Systems AB, FemoStopTM System (K915280) CardioThoracic Systems, Inc., CTS FloCoilTM Shunt (K970638) INTENDED USE/I… | 2004 |
| * | K915280 | FemostopSummary page 1…540) Classification: Class I1 PREDICATE DEVICES Cardiva Medical VasoStasis Vascular Closure System (K041486) Radi Medical Systems AB, FemoStopTM System (K915280) CardioThoracic Systems, Inc., CTS FloCoilTM Shunt (K970638) INTENDED USE/INDICATIONS FOR USE The Cardiva Medical Boomerang TM… | 1992 |
| * | K970638 | CTS Midcab Fixedn Diameter Coronary ShuntSummary page 1…CES Cardiva Medical VasoStasis Vascular Closure System (K041486) Radi Medical Systems AB, FemoStopTM System (K915280) CardioThoracic Systems, Inc., CTS FloCoilTM Shunt (K970638) INTENDED USE/INDICATIONS FOR USE The Cardiva Medical Boomerang TM Wire System is intended to promote hemostasis at arteriotomy… | 1997 |
What descends from it? (4)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K070485 | Boomerang Wire /Boomerang Plus Wire System, Model# B Plus Wire 58L | 2007 | 3 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All DXC devicesDXC Clamp, Vascular: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · DXC
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DXC
215in 2023
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DXC
2in 2023
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DXC
442in 2025
MAUDE reports naming product code DXC, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 10 | 52 | 0 | 298 |
| 2008 | 3 | 29 | 2 | 302 |
| 2009 | 4 | 83 | 2 | 539 |
| 2010 | 2 | — | 1 | 600 |
| 2011 | 6 | 51 | 3 | 691 |
| 2012 | 5 | 73 | 0 | 548 |
| 2013 | 14 | 89 | 0 | 920 |
| 2014 | 4 | 157 | 1 | 494 |
| 2015 | 5 | 71 | 0 | 374 |
| 2016 | 3 | 91 | 0 | 494 |
| 2017 | 3 | 90 | 0 | 416 |
| 2018 | 2 | — | 0 | 391 |
| 2019 | 2 | — | 0 | 393 |
| 2020 | 3 | 209 | 0 | 404 |
| 2021 | 6 | 37 | 0 | 371 |
| 2022 | 1 | — | 1 | 273 |
| 2023 | 4 | 215 | 2 | 674 |
| 2024 | 1 | — | 0 | 375 |
| 2025 | 2 | — | 0 | 442 |
| 2026 | 4 | 125 | 0 | — |
What is it indicated for?
The Boomerang TM Wire System is intended to promote hemostasis at an arteriotomy site as an adjunct to manual compression. The Boomerang TM Wire System is indicated for use in patients undergoing diagnostic and/or interventional femoral artery catheterization procedures using 5, 6 or 7 Fr introducer sheaths.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K051817 · printed Nov 6, 2026
Cite this page
510(k) Report. “K051817: Boomerang Closurewire Vascular Closure System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051817
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026